EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cannabidiol in Adults With Lennox–Gastaut Syndrome: Real‐World Experience

Pyae Aung iD, Debbie Miller, Emily Sewell, Laura Mantoan Ritter iD, Evangelia Theochari, Ioannis Stavropoulos iD, Robert Delamont, Mark P Richardson, Joel S Winston iD, Lina Nashef

European Journal of Neurology · 2026

DOI: 10.1111/ene.70760 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Neurology, 2026. Verfasst von Pyae Aung und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, King's College Hospital, London, UK. Hauptthemen laut MEDLINE: Lennox Gastaut Syndrome, Cannabidiol, Anticonvulsants. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jazz Pharmaceuticals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We report a single centre experience of cannabidiol use as adjunctive treatment in adults with Lennox–Gastaut Syndrome (LGS).

Methods

Retrospective review of adults with LGS treated with cannabidiol with clinical data collected from electronic records and caregiver standardised seizure diaries with seizure‐related outcomes assessed at baseline, 6 months, and last follow‐up.

Results

Seventy‐nine adults (median age 29 years; 40 male) were included. Median follow‐up was 41 months. Four patients died unrelated to cannabidiol treatment. Sixty‐seven (86%) remained on treatment at last follow‐up. Across all seizure types, 59.5% achieved ≥ 50% reduction at 6 months and 67.1% at last follow‐up. Among those with ‘Drop Seizures’ ( n = 78), 50% achieved > 50% reduction at 6 months and 61.5% at last follow‐up. ‘Drop Seizure’ responder rates were numerically higher with clobazam > 5 mg/day, but with no statistically significant dose–response relationship seen. Seizure‐free days increased (baseline 5.7/month; last follow‐up 12.5/month). Seizure‐related hospital admissions and injuries declined. Cognitive or behavioural improvements were reported in 48 patients (60.8%); there was no statistically significant association with achieving ≥ 50% seizure reduction. Drowsiness ( n = 33) was the most frequent adverse event often related to drug–drug interactions. Diarrhoea ( n = 24) was more common than previously reported. Side‐effects necessitated ASM adjustments in 51 patients. Fourteen were able to withdraw one or more ASMs.

Conclusions

CBD was associated with sustained effectiveness and good tolerability in adults with LGS, with high retention and improvement in seizure and other clinically meaningful outcomes. Adverse effects, mainly interaction‐related, were usually managed with concomitant medication adjustments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lennox Gastaut SyndromeCannabidiolAnticonvulsantsHumansMaleAdultRetrospective StudiesFemaleYoung AdultTreatment OutcomeMiddle AgedAdolescentFollow-Up StudiesSeizures

Stichwörter der Autor:innen

Lennox–Gastaut syndromecannabidiolepilepsyreal‐world evidenceseizure control

Substanzen

CannabidiolAnticonvulsants

Autor:innen und Institutionen

  • Department of Neurology, King's College Hospital, London, UK.
  • Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Department of Clinical Neurophysiology, King's College Hospital, London, UK.

ORCID-Profile: Pyae Aung, Laura Mantoan Ritter, Ioannis Stavropoulos, Joel S Winston

Förderung

  • Jazz Pharmaceuticals

Zitieren

APA

Aung, P., Miller, D., Sewell, E., Ritter, L. M., Theochari, E., Stavropoulos, I., Delamont, R., Richardson, M. P., Winston, J. S., & Nashef, L. (2026). Cannabidiol in Adults With Lennox–Gastaut Syndrome: Real‐World Experience. European Journal of Neurology. https://doi.org/10.1111/ene.70760

Vancouver

Aung P, Miller D, Sewell E, Ritter LM, Theochari E, Stavropoulos I, et al. Cannabidiol in Adults With Lennox–Gastaut Syndrome: Real‐World Experience. European Journal of Neurology. 2026. doi:10.1111/ene.70760

BibTeX
@article{Aung2026,
  author = {Aung, Pyae and Miller, Debbie and Sewell, Emily and Ritter, Laura Mantoan and Theochari, Evangelia and Stavropoulos, Ioannis and Delamont, Robert and Richardson, Mark P and Winston, Joel S and Nashef, Lina},
  title = {Cannabidiol in Adults With Lennox–Gastaut Syndrome: Real‐World Experience},
  journal = {European Journal of Neurology},
  year = {2026},
  doi = {10.1111/ene.70760}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche